Form 4 for PHVS Pharvaris N.V.
Accepted 2026-05-26 17:45:32 ET · period of report 2026-05-21 · accession 0001193125-26-239733 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-26 17:45 | 2026-05-21+ | PHVS | Nijdam Anna | Principal Accounting Off | M - OptEx | $20.00 | +7,330 | 54.4K | +16% | +$146.6K |
| DM | 2026-05-26 17:45 | 2026-05-21+ | PHVS | Nijdam Anna | Principal Accounting Off | S - Sale+OE | $30.70 | -7,330 | 48.9K | -13% | -$225.1K |
| DM | 2026-05-26 17:45 | 2026-05-21+ | PHVS | Nijdam Anna | Principal Accounting Off | M - OptEx | $0.00 | -7,330 | 22.7K | -24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | M | A | 1,829 | $20.00 | 50,774 | D | — | — | (F1) On April 14, 2026, the reporting person reported an RSU vesting transaction in which 5 additional shares were inadvertently reported as withheld for tax obligations, resulting in an understatement of total beneficial ownership. Following correction of the tax withholding share amount, total beneficial ownership as of April 11, 2026 should have been 48,945 shares rather than 48,940 shares reported previously. |
| 2 | Common | Common Stock | 2026-05-21 | S | D | 1,829 | $30.60 | 48,945 | D | — | — | (F2) The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $30.60 to $30.61. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2026-05-22 | M | A | 5,501 | $20.00 | 54,446 | D | — | — | |
| 4 | Common | Common Stock | 2026-05-22 | S | D | 5,501 | $30.74 | 48,945 | D | — | — | (F3) The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $30.60 to $31.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-05-21 | M | D | 1,829 | $0.00 | 28,171 | D | $20.00 · — to 2031-02-05 | 30,000 Common Stock | (F4) 25% of the option vested on February 5, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-05-22 | M | D | 5,501 | $0.00 | 22,670 | D | $20.00 · — to 2031-02-05 | 30,000 Common Stock | (F4) 25% of the option vested on February 5, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter. |